Imaging is critically important for the diagnosis and staging of patients with high-risk prostate cancer. While established prostate cancer staging guidelines have increased appropriate use of imaging, underuse for high-risk prostate cancer remains substantial. Several factors affect the utility of initial diagnostic imaging and, in this Review, Bjurlin and colleagues discuss the performance of conventional and emerging imaging modalities for diagnosing and staging high-risk prostate cancer.
- Marc A. Bjurlin
- Andrew B. Rosenkrantz
- Samir S. Taneja